RITTER PHARMACEUTICALS INC Business Finance Contracts & Agreements
98 Contracts & Agreements
- Debenture Agreements (3 contracts)
- Exchange Agreements (1)
- Funding Agreements (1)
- Investor Rights Agreements (5)
- Note Agreements (7)
- Purchase Agreements (16)
- Registration Rights Agreements (6)
- Release Agreements (1)
- Share Agreements (2)
- Stock Agreements (22)
- Underwriting Agreements (2)
- Waiver Agreements (3)
- Warrant Agreements (29)
- Form of Placement Agency Warrant (Filed With SEC on August 22, 2024)
- Form of Securities Purchase Agreement (Filed With SEC on August 22, 2024)
- Form of Pre-Funded Warrant (Filed With SEC on August 22, 2024)
- Form of Placement Agency Warrant (Filed With SEC on August 9, 2024)
- Form of Securities Purchase Agreement (Filed With SEC on August 9, 2024)
- Form of Pre-Funded Warrant (Filed With SEC on August 9, 2024)
- Form of Placement Agency Warrant (Filed With SEC on August 7, 2024)
- Form of Securities Purchase Agreement (Filed With SEC on August 7, 2024)
- Form of Pre-Funded Warrant (Filed With SEC on August 7, 2024)
- Promissory Note, dated July 12, 2024, issued by Qualigen Therapeutics, Inc. to Marizyme, Inc (Filed With SEC on July 18, 2024)
- Senior Note dated June 8, 2024 (Filed With SEC on July 15, 2024)
- Securities Purchase Agreement dated July 5, 2024 (Filed With SEC on July 11, 2024)
- Common Stock Purchase Warrant dated April 12, 2024, issued by us to Yi Hua Chen (Filed With SEC on April 16, 2024)
- 8% Convertible Debenture dated April 12, 2024, issued by us to Yi Hua Chen (Filed With SEC on April 16, 2024)
- Form of Common Stock Purchase Warrant to be issued by the Company to Alpha Capital Anstalt [Exhibit C to the Securities Purchase Agreement dated February 26, 2024] (Filed With SEC on February 27, 2024)
- Form of 8% Convertible Debenture to be issued by the Company to Alpha Capital Anstalt [Exhibit A to the Securities Purchase Agreement dated February 26, 2024] (Filed With SEC on February 27, 2024)
- Securities Purchase Agreement dated February 26, 2024 between the Company and Alpha Capital Anstalt (Filed With SEC on February 27, 2024)
- Amendment No. 1 with regard to Securities Purchase Agreement, dated December 5, 2023, between the Company and Alpha Capital Anstalt (Filed With SEC on December 7, 2023)
- Consent and Waiver, dated September 22, 2023, between Qualigen Therapeutics, Inc. and Alpha Capital Anstalt (Filed With SEC on September 28, 2023)
- Stock Purchase Agreement, dated July 20, 2023, by and between Qualigen Therapeutics, Inc., Chembio Diagnostics, Inc., Biosynex, S.A., and Qualigen, Inc (Filed With SEC on July 26, 2023)
- Registration Rights Agreement, dated December 22, 2022, by and between Qualigen Therapeutics, Inc. and Alpha Capital Anstalt (Filed With SEC on December 22, 2022)
- 8% Senior Convertible Debenture Due December 22, 2025 (Filed With SEC on December 22, 2022)
- Securities Purchase Agreement, dated December 21, 2022, by and between Qualigen Therapeutics, Inc. and Alpha Capital Anstalt (Filed With SEC on December 22, 2022)
- Common Stock Purchase Warrant for 2,500,000 shares in favor of Alpha Capital Anstalt, dated December 22, 2022 (Filed With SEC on December 22, 2022)
- Amendment No. 1 to the 2022 Employee Stock Purchase Plan of Qualigen Therapeutics, Inc (Filed With SEC on November 22, 2022)
- Qualigen Therapeutics, Inc. 2022 Employee Stock Purchase Plan (Filed With SEC on November 14, 2022)
- Pre-Funded Common Stock Purchase Warrant issued by the Company in favor of Alpha Capital Anstalt, dated May 26, 2022 (Filed With SEC on June 2, 2022)
- Master Agreement for the Operational and Technological Funding of NanoSynex between Qualigen Therapeutics, Inc. and NanoSynex Ltd., dated May 26, 2022 (Filed With SEC on June 2, 2022)
- Share Purchase Agreement between the Company and Alpha Capital Anstalt dated April 29, 2022 (Filed With SEC on May 13, 2022)
- Series B Preferred Share Purchase Agreement between the Company and NanoSynex Ltd. dated April 29, 2022 (Filed With SEC on May 13, 2022)
- Amended and Restated Common Stock Purchase Warrant to Christopher Nelson (300,000 shares) (Filed With SEC on May 13, 2022)
- Amended and Restated Common Stock Purchase Warrant to GreenBlock Capital LLC (300,000 shares) (Filed With SEC on May 13, 2022)
- Waiver and Amendment between Qualigen Therapeutics, Inc. and Alpha Capital Anstalt, dated November 29, 2021 (Filed With SEC on December 1, 2021)
- Securities Purchase Agreement, dated November 29, 2021 (Filed With SEC on December 1, 2021)
- Prefunded Common Stock Purchase Warrant for 1,000,000 shares, dated December 18, 2020 (Filed With SEC on December 18, 2020)
- Deferred Common Stock Purchase Warrant for 842,696 shares, dated December 18, 2020 (Filed With SEC on December 18, 2020)
- Two-Year Common Stock Purchase Warrant for 1,348,314 shares, dated December 18, 2020 (Filed With SEC on December 18, 2020)
- Securities Purchase Agreement, dated December 16, 2020 (Filed With SEC on December 18, 2020)
- Common Stock Purchase Warrant for 1,287,829 shares, dated August 4, 2020 (Filed With SEC on August 4, 2020)
- Securities Purchase Agreement, dated August 2, 2020 (Filed With SEC on August 4, 2020)
